(E)-N-(2-(1H-imidazol-1-yl)-2-(4-(trifluoromethyl)phenyl)ethyl)-3-styrylbenzamide

ID: ALA4066700

PubChem CID: 132576475

Max Phase: Preclinical

Molecular Formula: C27H22F3N3O

Molecular Weight: 461.49

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCC(c1ccc(C(F)(F)F)cc1)n1ccnc1)c1cccc(/C=C/c2ccccc2)c1

Standard InChI:  InChI=1S/C27H22F3N3O/c28-27(29,30)24-13-11-22(12-14-24)25(33-16-15-31-19-33)18-32-26(34)23-8-4-7-21(17-23)10-9-20-5-2-1-3-6-20/h1-17,19,25H,18H2,(H,32,34)/b10-9+

Standard InChI Key:  CNOVPBCKUAHRKG-MDZDMXLPSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    8.5091  -10.6879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5091  -11.5051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8000  -11.9137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0909  -11.5051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0909  -10.6879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8000  -10.2793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3819  -11.9137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6769  -11.5051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9678  -11.9137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9678  -12.7309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2628  -13.1395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5538  -12.7309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5538  -11.9137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2628  -11.5051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2167  -11.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9245  -11.5057    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.2163  -12.7312    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6321  -11.9146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3400  -11.5063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0475  -11.9152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3403  -10.6891    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9967  -10.2076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7445   -9.4303    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9272   -9.4299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6745  -10.2070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0443  -12.7294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7510  -13.1383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4598  -12.7299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4576  -11.9085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7503  -11.5034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1679  -13.1379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1687  -13.9551    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.8753  -12.7286    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.8704  -13.5456    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  2  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  9 14  2  0
  4  7  1  0
  2 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 21  1  0
 20 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 20  1  0
 28 31  1  0
 31 32  1  0
 31 33  1  0
 31 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4066700

    ---

Associated Targets(Human)

CYP24A1 Tchem Cytochrome P450 24A1 (161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 461.49Molecular Weight (Monoisotopic): 461.1715AlogP: 6.09#Rotatable Bonds: 7
Polar Surface Area: 46.92Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.71CX LogP: 5.96CX LogD: 5.90
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.34Np Likeness Score: -1.08

References

1. Taban IM, Zhu J, DeLuca HF, Simons C..  (2017)  Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides.,  25  (15): [PMID:28601511] [10.1016/j.bmc.2017.05.055]
2. Bruno, Robert D RD and Njar, Vincent C O VC.  2007-08-01  Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.  [PMID:17544277]
3. Taban, Ismail M IM, Zhu, Jinge J, DeLuca, Hector F HF and Simons, Claire C.  2017-08-01  Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides.  [PMID:28601511]

Source